This invention proposes a
drug target interaction prediction method based on graph interaction and multi-
granularity fusion, belonging to the field of
bioinformatics. Addressing issues such as oversmoothing of
graph neural networks in heterogeneous graphs, insufficient utilization of
drug-target interactions and multi-scale information, and poor adaptability of multi-
branch feature splicing, an
improved method is proposed. First, a deep interactive graph neural network
branch is constructed on the node adaptive local
smoothing features and the heterogeneous graph composed of
drug-drug, target-target, and drug-target edges, realizing
message passing and fusion of classification edges and introducing residual connections. Second, a dual-
tower interactive
branch is constructed for multi-order interactions. Third, a multi-
granularity fusion branch is constructed to achieve progressive fusion of multi-scale features. Finally, the multi-branch representations are weighted and fused through a gating network, combined with the output results of a
perceptron and a
sigmoid function, and optimized using binary cross-entropy. This invention improves prediction performance and
interpretability, and is applicable to scenarios such as
drug discovery and target screening.